A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was as follows: is coronary artery bypass graft (CABG) surgery superior to percutaneous coronary intervention (PCI) in terms of in-hospital mortality and morbidity and long-term outcomes in patients with acute myocardial infarction (MI)? A total of 104 papers were returned using the selected search. Of these, six represented the best evidence to answer the clinical question. The selection criteria were comparative studies with only PCI and CABG groups in patients with acute MI. Case reports, reviews, recommendations and studies on a specific population or out of the context of acute MI were excluded. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Almost all PCI patients received stents. One study used drug-eluting stents (DES). Two randomized studies showed similar short-and mid-term morbidities and mortalities in patients with acute MI in the PCI and CABG groups but higher repeat revascularization rates after PCI. Three observational studies found comparable survival, but one of them found more periprocedural events with CABG and the other two found more recurrent ischaemia requiring repeat revascularization in the PCI group. In one cohort study, CABG appeared to be an independent risk factor for death in N-STEMI according to the European Society/American College of Cardiology 2000 definition. The results are strongly influenced by the definition of acute MI. In an institution offering the two techniques with an equivalent accessibility, the principal advantage of PCI is a lower incidence of periprocedural and short-term morbidities. CABG, on the other hand, offers a better durability with less mid-term repeat revascularization required, especially when compared with PCI with DES implantation. Choice had to weight up coronary artery anatomy, number and localization of coronary artery stenosis and accessibility of both PCI and CABG treatments. Medical and surgical discussion within the Heart Team is required to make the best medical decision for each patient.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION

In [patients with acute myocardial infarction] is [coronary artery bypass grafting] superior to [percutaneous coronary artery intervention] in terms of [adverse outcomes]?
CLINICAL SCENARIO
A 65-year old male with an acute myocardial infarction (MI) is transferred to the cardiac catheterization laboratory. A coronary angiogram showed triple vessel disease with an occlusion of the right coronary artery and a complex stenosis of the left anterior descending artery. His case is discussed within the multidisciplinary Heart Team. The question is whether percutaneous coronary intervention (PCI), which is less invasive than coronary artery bypass graft (CABG) surgery, would carry similar mortality, morbidity and freedom from repeat revascularization. 
SEARCH STRATEGY
SEARCH OUTCOME
A total of 104 papers were found using the designated search. From these, six papers comparing the two treatments of interest in acute MI were identified, which provided the best evidence to answer the study question. These are presented in Table 1 .
RESULTS
In a randomized trial, de Feyter et al. [2] compared the results of PCI using bare-metal stents (BMS) with CABG using arterial grafts in patients with multivessel coronary artery disease. For patients with unstable angina, freedom from major adverse events at 1 year, including death, MI and cerebrovascular events, was similar in the two groups. At 1 year, repeat revascularization was significantly higher in those patients who underwent PCI compared with the CABG groups. Zhang et al. [3] had similar results in a randomly controlled trial comparing outcomes of PCI using BMS vs CABG in patients with acute coronary syndrome (ACS) and non-ACS. At 6 months, a greater relative benefit favouring CABG was noted in terms of physical limitation and freedom of angina. However, this benefit decreased at 1 year [6] .
In a propensity-matched comparison from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial [5] , Ben-Gal et al. [4] showed that patients with multivessel disease treated with PCI rather than CABG had lower rates of periprocedural stroke, MI, major bleeding and renal injury with comparable 1-month and 1-year mortality rates. In the PCI group, however, they observed a higher rate of recurrent ischaemia requiring repeat revascularization. Type, number of grafts used, off-/ on-pump techniques employed and rate of stent implantation were not described [4] . In addition, the ACUITY trial was designed to compare three different antithrombotic regimens (unfractionated heparin or enoxaparin with a glycoprotein IIb/IIIa inhibitor, bivalirudin with a glycoprotein IIb/IIIa inhibitor or bivalirudin alone) that were not specified in this subgroup analysis, even if they may have influenced thrombotic or bleeding events.
In a similar subgroup observational study, Caggegi et al. [6] studied the outcomes of PCI with drug-eluting stents (DES) vs CABG in consecutive patients with unprotected left main coronary artery disease presenting with ACS. In the unadjusted analysis, patients who underwent PCI had worse clinical risk profiles, whereas patients who underwent CABG had higher angiographic risk profiles. This selection bias may be explained by the study design, given that PCI was chosen instead of CABG because of a subject's or physician's preference or high risk associated with CABG. Nevertheless, at 1-year follow-up, PCI with DES was found to be similar to CABG for death and MI, but was associated with more frequent repeat revascularizations.
White et al. [7] studied survival of patients with predominant left ventricular failure who had PCI or CABG revascularizations. Patients selected for CABG were more likely to have diabetes and more severe coronary disease than those selected for PCI. Despite these risk factor disparities, the survival rates at 30 days and 1 year were similar, even if the time from the onset of acute MI to revascularization was significantly longer in patients treated with CABG. Complete revascularization was achieved in 23.1 and 87.2% of the patients in the PCI and CABG groups, respectively, with no influence on survival at 30 days and 1 year.
Hochholzer et al. [9] , in a cohort study, found that patients with N-STEMI, according to the European Society/American College of Cardiology (ESC/ACC) definition [10] , had excessive cumulative 3-year mortality if undergoing CABG, while patients with unstable angina or N-STEMI according to the World Health Organization (WHO) definition [11] had similar long-term mortality in the two groups. In ESC/ACC N-STEMI patients, CABG as a primary therapy emerged as a predictor for death during follow-up. ESC/ACC N-STEMI patients were significantly older and more often had impaired renal function and multivessel coronary artery disease. In this group, CABG patients had significantly more impaired renal function, impaired left ventricular function, multivessel disease, diuretic therapy and high CRP levels, but CABG remained associated with higher mortality after adjustment. In unstable angina and N-STEMI according to the WHO definition, initial mortality was lower with PCI, but PCI patients had higher event rates during follow-up. The results are strongly dependent on the definition criteria for acute MI. The MI definition has been subsequently updated [12] .
CLINICAL BOTTOM LINE
Two randomized studies found similar short-and mid-term morbidities and mortalities for PCI and CABG in acute MI, but a higher repeat revascularization rate after PCI. Three observational studies found comparable survival, one of these with more periprocedural events with CABG and the other two with more recurrent ischaemia requiring repeat revascularization for PCI. In one cohort study, CABG was an independent risk factor for death in N-STEMI according to the ESC/ACC 2000 definition. PCI seems to have better shortterm outcomes, but CABG appears to result in less need for repeat revascularization and similar mid-and long-term outcomes.
